caa a22 4500 477061567 CHVBK 20180405111402.0 cr unu---uuuuu 170330e19960301xx s 000 0 eng 10.1007/BF01061912 doi (NATIONALLICENCE)springer-10.1007/BF01061912 Raskob Gary Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma aut Low molecular weight heparin in the prevention and treatment of venous thromboembolism [Elektronische Daten] [Gary Raskob] Several low molecular weight (LMW) heparin preparations have been evaluated by clinical trials measuring the outcomes of thromboembolism, bleeding, and mortality. This article summarizes the current status of LMW heparin in the prevention and treatment of venous thromboembolism. LMW heparin is simpler to use because it does not require laboratory monitoring of the anticoagulant effect and dose adjustment. The specific LMW heparins include enoxaparin, ardeparin, tinzaparin, dalteparin, and nadroparin. The heparinoid ORG 10172 (danaparoid) is also effective. The results of clinical trials to date suggest that LMW heparin will be a major advance in the treatment of patients with venous thromboembolism. The simplified therapy provided by LMW heparin may allow many patients with uncomplicated proximal-vein thrombosis to be cared for in an outpatient setting. Kluwer Academic Publishers, 1996 heparin nationallicence venous thromboembolism nationallicence cost effectiveness nationallicence Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 2/4(1996-03-01), 279-284 0929-5305 2:4<279 1996 2 11239 https://doi.org/10.1007/BF01061912 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01061912 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Raskob Gary Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma aut NATIONALLICENCE 773 0- Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 2/4(1996-03-01), 279-284 0929-5305 2:4<279 1996 2 11239 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer